Literature DB >> 16137996

Local resection of rectal tumors by transanal endoscopic microsurgery: experience with the first 70 cases.

O Røkke1, K B Iversen, K Ovrebø, H Maartmann-Moe, A Skarstein, J F Halvorsen.   

Abstract

BACKGROUND: Transanal endoscopic microsurgery (TEM) can access the whole rectum up to 20 cm from the anal verge. Due to its excellent view and accurate dissection, TEM is useful for the removal of adenoma and selected low risk cancers of the rectum. We report our experience with the first 70 patients presenting.
METHODS: A prospective descriptive study of 70 patients treated for rectal tumor with TEM from December 99 until October 2002 at Haukeland University Hospital.
RESULTS: TEM was performed in 37 men and 33 women, median age 70.5 (19-90) years, for anticipated adenoma (n = 64), adenocarcinoma (n = 3), rectal ulcer (n = 1), and re-resection after snare resection of rectal polyp with adenocarcinoma (n = 1) and carcinoid tumor (n = 1). The median observation time was 12 (1-33) months. The distance from the anal verge to the lower tumor border was 5.5 (2.5-14) cm. The median resected area was 15.4 (1.5-132) cm(2). 56 of the 64 anticipated adenomas were true adenoma, resected without recurrences; 8 (12.5%) were unexpected adenocarcinoma. Three of these underwent a secondary rectal resection and 5 patients have been observed without recurrence. Of the 3 patients with known adenocarcinoma, there was one recurrence which was treated with a secondary curative rectal resection.
CONCLUSIONS: TEM can access tumors in the whole rectum. Large tumors may be removed with low frequency of per- and postoperative complications and short hospital stay. TEM is highly useful for removal of rectal adenoma. A role for primary treatment of selected low-risk rectal cancers may emerge. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16137996     DOI: 10.1159/000087972

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  7 in total

1.  A new proctoscope for transanal endoscopic operations.

Authors:  J J Ribeiro da Rocha; O Féres
Journal:  Tech Coloproctol       Date:  2008-08-05       Impact factor: 3.781

Review 2.  Surgical resection of rectal adenoma: a rapid review.

Authors:  Damian Casadesus
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

3.  Risk factors for recurrence after transanal endoscopic microsurgery for rectal malignant neoplasm.

Authors:  Mario Morino; Marco Ettore Allaix; Mario Caldart; Gitana Scozzari; Alberto Arezzo
Journal:  Surg Endosc       Date:  2011-06-07       Impact factor: 4.584

Review 4.  Transanal endoscopic microsurgery.

Authors:  M Morino; A Arezzo; M E Allaix
Journal:  Tech Coloproctol       Date:  2013-01-12       Impact factor: 3.781

5.  Rectal adenocarcinoma and transanal endoscopic microsurgery. Diagnostic challenges, indications and short term results in 142 consecutive patients.

Authors:  G Baatrup; H Elbrønd; P Hesselfeldt; P Wille-Jørgensen; P Møller; B Breum; N Qvist
Journal:  Int J Colorectal Dis       Date:  2007-07-21       Impact factor: 2.571

Review 6.  Transanal endoscopic microsurgery: exploring its indications and novel applications. A narrative review.

Authors:  Xiaoqiang Xue; Guole Lin
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-09-01       Impact factor: 1.195

7.  Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study).

Authors:  Frank J C van den Broek; Eelco J R de Graaf; Marcel G W Dijkgraaf; Johannes B Reitsma; Jelle Haringsma; Robin Timmer; Bas L A M Weusten; Michael F Gerhards; Esther C J Consten; Matthijs P Schwartz; Maarten J Boom; Erik J Derksen; A Bart Bijnen; Paul H P Davids; Christiaan Hoff; Hendrik M van Dullemen; G Dimitri N Heine; Klaas van der Linde; Jeroen M Jansen; Rosalie C H Mallant-Hent; Ronald Breumelhof; Han Geldof; James C H Hardwick; Pascal G Doornebosch; Annekatrien C T M Depla; Miranda F Ernst; Ivo P van Munster; Ignace H J T de Hingh; Erik J Schoon; Willem A Bemelman; Paul Fockens; Evelien Dekker
Journal:  BMC Surg       Date:  2009-03-13       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.